Status:
RECRUITING
Early Pulmonary Dysfunction in Childhood Cancer Patients
Lead Sponsor:
University Children's Hospital Basel
Conditions:
Pulmonary Dysfunction
Eligibility:
All Genders
4-22 years
Brief Summary
This longitudinal, prospective, multicentre study is to monitor lung function prospectively in childhood cancer patients after diagnosis. The impact of cancer treatment on pulmonary dysfunction non-in...
Eligibility Criteria
Inclusion
- at least one of the following cancer treatments:
- chest radiation
- treatment with any kind of chemotherapy
- hematopoietic stem cell transplantation (HSCT)
- thoracic surgery
- consent for Childhood Cancer Registry (ChCR) registration
Exclusion
- no signed informed consent
- Operation outside the chest area as only cancer treatment
- Relapsed cancer (patients who develop relapse during the study will not be excluded)
- In addition for MRI and lung function tests:
- Subjects who are respiratory insufficient and cannot perform a lung function test (less than 92% O2 saturation; under O2 therapy)
- Pregnant
- MRI measurement not possible without sedation
- Metal (e.g. pacemaker) in the body
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2051
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT05427136
Start Date
June 1 2021
End Date
June 1 2051
Last Update
March 26 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
University Children's Hospital Basel (UKBB)
Basel, Switzerland, 4056
2
Universitätsklinik für Kinderheilkunde
Bern, Switzerland, 3010
3
Geneva University Hospital
Geneva, Switzerland, 1211
4
Centre hospitalier universitaire vaudois Lausanne
Lausanne, Switzerland, 1011